Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Publications section updated to clarify that publications are provided voluntarily by the person entering study information. The revision tag is updated to v3.3.2, replacing the old v3.2.0 wording.
    Difference
    0.1%
    Check dated 2025-11-26T13:47:46.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page no longer shows the site-wide government funding status notice. The study details and data presented on the page remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-19T09:24:41.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page content appears unchanged with no additions or deletions impacting core information, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-10-28T17:54:59.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links; replaces v3.1.0.
    Difference
    1%
    Check dated 2025-10-06T08:18:36.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.0%
    Check dated 2025-09-29T04:50:41.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2; core content remains unchanged, and the 'Back to Top' link was removed as a minor UI adjustment.
    Difference
    0.1%
    Check dated 2025-09-14T23:08:32.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.